New advances in acute graft-versus-host disease prophylaxis

This publication has 50 references indexed in Scilit:

• Interleukin-1 blockade does not prevent acute graft-versus-host disease: results of a randomized, double-blind, placebo-controlled trial of interleukin-1 receptor antagonist in allogeneic bone marrow transplantation
  Blood, 2002
• Immune reconstitution without graft-versus-host disease after haemopoietic stem-cell transplantation: a phase 1/2 study
  The Lancet, 2002
• A phase I/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation
  Bone Marrow Transplantation, 2002
• Second EBMT Workshop on reduced intensity allogeneic hemopoietic stem cell transplants (RI-HSCT)
  Bone Marrow Transplantation, 2002
• Do corticosteroids add any benefit to standard GVHD prophylaxis in allogeneic BMT?
  Bone Marrow Transplantation, 2001
• ALLOGENEIC TRANSPLANTATION ACROSS THE HLA BARRIERS
  Reviews in Clinical and Experimental Hematology, 2001
• Toxicity and Efficacy of Defined Doses of CD4+ Donor Lymphocytes for Treatment of Relapse After Allogeneic Bone Marrow Transplant
  Blood, 1998
• Impairment of leukaemia-free survival by addition of interleukin-2-receptor antibody to standard graft-versus-host prophylaxis
  The Lancet, 1995
• Successful Allogeneic Transplantation of T-Cell–Depleted Bone Marrow from Closely HLA-Matched Unrelated Donors
  New England Journal of Medicine, 1990
• Clinical Study of Gut Decontamination in Bone Marrow Transplantation
  Kansenshogaku Zasshi, 1988